Excessive Differentiation of Myeloid Cells in AML-M2 with Translocation 8;21

  • O. Haus
  • M. Czarnecka
  • K. Kuliczkowski
  • I. Makowska
  • S. Kotlarek-Haus
Conference paper
Part of the Haematology and Blood Transfusion / Hämatologie und Bluttransfusion book series (HAEMATOLOGY, volume 39)

Abstract

t(8;21) is a chromosomal abnormality found in a part of AML-M2 cases and exceptionally in other blood disorders. According to literature data, CR in this form of M2 is easy to obtain and therefore BMT is not recommended in the first remission. We report here on 3 patients observed in the past 3 years, in whom blood disease was firstly diagnosed as blast crisis/acceleration of CML, because of an excessive differentiation of their leukemic cells and low FAG scores. These results prompted us to diagnose BC/ACC-CML and to administer a proper therapy. However, cytogenetic examination of BM cells of the patients did not confirm the diagnosis: t(8;21) and no Ph chromosome was found in all samples examined, which enabled us to change the diagnosis. During the course of the disease a disappea-rance of t(8;21) in remissions and reappearance in relapses was revealed. t(8;21) is very rarely seen in BC-CML of M2 type and was never described in Ph(-) CML. Our observation confirm that of Yamasaki and co. that t(8;21) M2 may show an excessive differentiation of the myeloid cell line.

Keywords

Leukemia Pneumonia Anemia Oncol Sarcoma 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Second MIC Cooperative Study Group (1988) Morphologic, immunologic and cytogenetic (MIC) working classification of the acute myeloid leukemias. Br J Haematol, 68: 487–494CrossRefGoogle Scholar
  2. 2.
    Okuda T, van Deursen J, Hiebert SW, Grosveld G, Downing JR (1996) AML 1, the target of multiple chromosomal translocations in human leukemia, is essential for normal liver hematopoiesis. Cell, 84: 321–330PubMedCrossRefGoogle Scholar
  3. 3.
    Asou H, Tashiro S, Hamamoto K, Otsuji A, Kita K, Kamada N (1991) Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with t(8;21) chromosome translocation. Blood, 77: 2031–2036PubMedGoogle Scholar
  4. 4.
    Kamada N, Okada K, Oguma N, Tanaka R, Mika-mi M, Uchino H (1976) C-G translocation in acute myelocytic leukemia with low neutrophil alkaline phosphatase activity. Cancer, 37: 2380–2387PubMedCrossRefGoogle Scholar
  5. 5.
    Krishnan K, Ross CW, Adams PT, Pereira A, Roth MS (1994) Neural cell-adhesion molecule (CD56)–positive, t(8;21) acute myeloid leukemia (AML,M-2) and granulocytic sarcoma. Ann Hematol, 69: 321–323PubMedCrossRefGoogle Scholar
  6. 6.
    Touw I, Donath K, Pouwels U, van Buitenen C, Schipper P, Santini V, Hagemeijer A, Lowenberg B, Delwel R (1991) Acute myeloid leukemias with chromosomal abnormalities involving the 21g22 region identified by their in vitro responsiveness to interleukin-5. Leukemia, 5: 687–692PubMedGoogle Scholar
  7. 7.
    Sun G, Sparkes RS, Wormsley S, Naeim F, Champlin R, Gale RP (1990) Are some cases of acute leukemia with t(8;21) hybrid leukemias? Cancer Genet Cytogenet, 49: 177–184PubMedCrossRefGoogle Scholar
  8. 8.
    Fenaux P, Lai JL, Preudhomme C, Jouet JP, Deminatti H, Bauters F (1990) Is translocation (8;21) a “favourable” cytogenetic rearrangement in acute myeloid leukemia ? Nouv Rev Hematol, 32: 179–182Google Scholar
  9. 9.
    Yamasaki H, Era T, Asou N, Sanada I, Matutes E, Yamaguchi K, Takatsuki K (1995) High degree of myeloid differentiation and granulocytosis is associated with t(8;21) smoldering leukemia. Leukemia, 9: 1147–1153PubMedGoogle Scholar
  10. 10.
    Tallman MS, Hakimian D, Shaw JM, Lissner GS, Russell EJ,Variakojis D (1993) Granulocytic sarcoma is associated with the 8;21 translocation in acute myeloid leukemia. J Clin Oncol, 11, 690–697Google Scholar
  11. 11.
    Kwong YL, Ching ML, Liu HW, Lee CP, Pollock A, Chan LC (1993) 8;21 translocation and multilineage involvement. Am J Hematol, 43: 212–216PubMedCrossRefGoogle Scholar
  12. 12.
    Galvani DW, Banghar P, Mekawi L (1995) Early identification of M2 AML with the t(8;21) translocation plus myelodysplastic features. Leukemia Res, 19: 145CrossRefGoogle Scholar
  13. 13.
    Maserati E, Casali M, Pasquali F, Locatelli F, Gia-ni S, Prete L, Zecca M, Invernizzi R, Bassan R (1992) Translocation (8;21) in two cases of refractory anemia with excess of blasts in transformation. Cancer Genet Cytogenet, 58: 76–78PubMedCrossRefGoogle Scholar
  14. 14.
    Fasanaro A, Paone G, Silvestri J, Marottoli V, Cimino R, Ferrara F (1994) Early blastic transformation of a myeloproliferative disorder with t(8;21) and progressive aberrations of chromosome 8. Cancer Genet Cytogenet, 75: 106–110PubMedCrossRefGoogle Scholar
  15. 15.
    Raskind WH, Papayannopolu T, Hammond WP (1988) t(8;21) with a phenotype of chronic myeloid leukemia. Am J Hematol, 28: 266–272PubMedCrossRefGoogle Scholar
  16. 16.
    de Greef GE, Hagemeijer A, Morgan R, Wijsman J, Hoefsloot LH, Sandberg AA, Sacchi NN (1995) Leukemia, 9: 282–287PubMedGoogle Scholar
  17. 17.
    Ferro MT, Steegman JL, Escribano L, Heiurichs B, Parada L, Garcia-Sagredo JM, Resino M, Cabello P, San Roman C (1992) Ph-positive chronic myeloid leukemia with t(8;21)(g22;g22) in blastic crisis. Cancer Genet Cytogenet, 58: 96–99.PubMedCrossRefGoogle Scholar
  18. 18.
    ISCN (1991) Guidelines for Cancer Cytogenetics, Supplement to An International System for Human Cytogenetic Nomenclature. Mitelman E(ed); S.Karger, BaselGoogle Scholar
  19. 19.
    ISCN (1995) An International System for Human Cytogenetic Nomenclature. Mitelman F. (ed); S. Karger, BaselGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1998

Authors and Affiliations

  • O. Haus
    • 1
  • M. Czarnecka
    • 2
  • K. Kuliczkowski
    • 2
  • I. Makowska
    • 2
  • S. Kotlarek-Haus
    • 2
  1. 1.Department of GeneticsUniversity of MedicineWroclawPoland
  2. 2.Department of HaematologyUniversity of MedicineWroclawPoland

Personalised recommendations